The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monday Deal Review: April 13, 2009

M&A, scads of securities, and a real, live IPO in the Canadian deal news this week.

M&A:

Commercial Deals:

Securities:

Debt:

Clinical Trials:

Bookmark and Share

About these ads

3 responses to “Monday Deal Review: April 13, 2009

  1. Pingback: Monday Deal Review: May 4, 2009 « The Cross-Border Biotech Blog

  2. Pingback: Monday Deal Review: July 12, 2009 « The Cross-Border Biotech Blog

  3. Pingback: Lonza Emerges as Patheon’s White Knight with $460 Million Bid « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers